{"id":"tp-62219","type":"article-newspaper","title":"Belite Bio Shares Fall 13% as FDA Sets New Tinlarebant Action Date","author":"Riza Dagoc","publisher":"TOKENPOST Inc.","url":"https://www.tokenpost.com/news/regulation/62219","datePublished":"2026-11-20T17:14:07.000Z","dateModified":"2026-11-20T17:14:07.000Z","language":"en","abstract":"The FDA set May 12, 2027, as the new action date for tinlarebant’s application for Stargardt disease type 1.","section":"Regulation","references":[]}